SCHEDULE: Todd W. Fennell Discloses 9.8% Stake in Prothena Corp

Todd W. Fennell has filed a Schedule 13G, reporting beneficial ownership of approximately 9.8% of Prothena Corp Public Ltd Co's ordinary shares as of June 30, 2026.

Summary

• Todd W. Fennell, through various trusts and grantor retained annuity trusts where he serves as an independent trustee, may be deemed the beneficial owner of 5,010,846 ordinary shares of Prothena Corp Public Ltd Co.
• This holding represents approximately 9.8% of the company's outstanding ordinary shares, based on the issuer's Form 10-Q for the quarter ended June 30, 2026.
• The filing explicitly states that Fennell disclaims beneficial ownership of shares where he does not have a pecuniary interest and denies being part of a group with any other party.
• A power of attorney document was also filed, appointing Reid E. Buchanan and Diana L. Hayes as attorneys-in-fact to handle SEC filings and related matters for Fennell.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily an administrative disclosure of beneficial ownership rather than a strategic or financial update.

Positives

• Disclosure of significant beneficial ownership can indicate investor confidence or a strategic interest in the company.
• The filing is up-to-date, reflecting shareholdings as of June 30, 2026.

Negatives

• The filing does not provide any new financial performance data or strategic insights into Prothena Corp.
• The nature of the beneficial ownership is through trusts, which may imply indirect control or influence rather than direct personal investment.

Risks

• While not explicitly stated as a risk in this filing, significant ownership by a single entity or individual can sometimes lead to concentrated decision-making or potential future activist involvement.
• The filing does not contain forward-looking statements, thus no specific future risks are detailed within this document.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or future outlook for Prothena Corp.

Management Comments

• The Reporting Person may be deemed to be the beneficial owner of 5,010,846 Ordinary Shares.
• The Reporting Person disclaims beneficial ownership of all Ordinary Shares to which the Reporting Person does not have a pecuniary interest, and the Reporting Person expressly disclaims any status as a group with any other party.
• By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant individual holders who acquire more than 5% of a company's stock. This filing indicates a substantial passive investment in Prothena Corp, a biotechnology company.

Stakeholder Impact

• Shareholders: The filing confirms a significant passive stake, which could be a factor in future corporate actions or governance discussions, though no immediate impact is indicated.
• Management: The disclosure is a standard regulatory requirement and does not directly imply any immediate impact on management's strategic direction.

Next Steps

• Todd W. Fennell, through his appointed attorneys-in-fact, will continue to comply with SEC reporting requirements for his beneficial ownership of Prothena Corp shares.
• Future filings will be made if there are any material changes in beneficial ownership.

Key Dates

Keywords

Prothena Corp, Schedule 13G, Beneficial Ownership, Ordinary Shares, Todd W. Fennell, SEC Filing, Trustee, Investment